Irritable Bowel Syndrome
Irritable Bowel Syndrome
SIBO (Small intestine Bacterial Overgrowth)
Irritable bowel syndrome is a common disorder with symptoms of abdominal pain, altered bowel pattern (diarrhea or constipation) and abdominal bloating. It is likely a diverse group of disorders with more than one cause, however recent research has focused on SIBO (small intestinal bacterial overgrowth) as a probable mechanism in a subset of IBS patients. Recent studies have been able to show a link between gut bacteria and the production of symptoms. SIBO is a clinical condition characterized by an abnormally high population of both aerobic and anaerobic coliform bacteria. Several conditions predispose patients to the development of SIBO: anatomic obstruction, autonomic neuropathy, and surgical revision.
There is breath testing available for SIBO however this is usually only performed in the University setting. Breath testing can be difficult and complex to interpret and although breath testing appears to be more commonly abnormal in IBS patients based on studies this test is imperfect for definitively identifying SIBO.
Evidence of the involvement of bacteria in IBS provides a rationale for the potential therapeutic benefit of antibiotic treatment. Several studies have shown that systemic antibiotics eradicate SIBO and improve bowel symptoms. Several broad-spectrum absorbable antibiotics have successfully reduced overgrowth: tetracycline, amoxicillin clavulanate (Augmentin), metronidazole (Flagyl), and fluoroquinolones (such as norfloxacin); however, these drugs are not without systemic side effects. Nonabsorbable/topical antibiotics that act strictly on the gut lumen (have no systemic absorption) have been utilized to avoid systemic side effects by selectively eradicating gut flora. Rifaximin (Xifaxan) has been shown to be effective, has a low incidence of resistance, and has few side effects. In addition to its beneficial safety profile and antimicrobial characteristics, rifaximin has demonstrated a significant benefit for treating SIBO based on breath tests and therefore has become the treatment of choice. Ask your doctor is treatment is appropriate for you.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- irritable bowel syndrome
- gentamicin clinical guidelines for dosing and monitoring
- evaluation of the impact of zinc and or micronutrient
- aga technical review on the evaluation and management of
- approach to the patient with gas and bloating
- c 14 breath test xylose for investigation of
- screening and importance of early diagnosis level 2
Related searches
- bowel prep for prostate mri
- over the counter bowel cleanse
- sjogren s and bowel problems
- ischemic bowel icd 10
- icd 10 small bowel obstruction unspecified
- icd 10 code for small bowel obstructions
- dilated small bowel icd 10
- dilated bowel loops icd 10
- icd 10 large bowel obstruction
- bowel cleansing for colonoscopy
- how bowel movement works
- how the bowel system works